Sign In
Buy ZBH
$84.98
+1.23 (+1.47%)
At Close: Jun 03, 2026
Wide-Moat Stocks On Sale - The June 2022 Heat Map
07:20am, Tuesday, 31'st May 2022 Seeking Alpha
Our 3-step process focuses on wide-moat stocks (as per Morningstar’s rating). We are only interested in those targets that are attractively valued in historical comparison.
Benzinga's Top Ratings Upgrades, Downgrades For May 27, 2022
03:36pm, Friday, 27'th May 2022 Benzinga
Upgrades
According to Bernstein, the prior rating for HCA Healthcare Inc (NYSE:HCA) was changed from Market Perform to Outperform. HCA Healthcare earned $4.12 in the first quarter, compared to $4.14 i
5 Analysts Have This to Say About Zimmer Biomet Holdings
03:08pm, Friday, 27'th May 2022 Benzinga
Within the last quarter, Zimmer Biomet Holdings (NYSE:ZBH) has observed the following analyst ratings:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
1
1
3
0
0
Zimmer Biomet Is Hobbling Behind The Market
08:54am, Wednesday, 25'th May 2022
Zimmer Biomet has greatly underperformed the S&P 500 as well as the iShares IHI, been stagnant over the past 5 years. The street consensus gives some hope for the projected growth with an estimated 28
Here's Why Investors Should Retain Zimmer Biomet (ZBH) Now
04:01pm, Tuesday, 17'th May 2022 Zacks Investment Research
Investors are optimistic about Zimmer Biomet's (ZBH) better-than-expected revenues and robust performance across several geographies.
Here's Why Investors Should Retain Zimmer Biomet (ZBH) Now
01:32pm, Tuesday, 17'th May 2022
Investors are optimistic about Zimmer Biomet's (ZBH) better-than-expected revenues and robust performance across several geographies.
Zimmer Biomet's (ZBH) Procedure Volume Grows, Costs Rise
03:16pm, Monday, 09'th May 2022 Zacks Investment Research
Zimmer Biomet's (ZBH) recently completed the spin-off of the non-core dental and spine business is expected to prove strategic.
Zimmer Biomet's (ZBH) Procedure Volume Grows, Costs Rise
12:47pm, Monday, 09'th May 2022
Zimmer Biomet's (ZBH) recently completed the spin-off of the non-core dental and spine business is expected to prove strategic.
SVB Leerink Maintains Outperform Rating for Zimmer Biomet Holdings: Here's What You Need To Know
04:14pm, Wednesday, 04'th May 2022 Benzinga
SVB Leerink has decided to maintain its Outperform rating of Zimmer Biomet Holdings (NYSE:ZBH) and raise its price target from $135.00 to $140.00.
Shares of Zimmer Biomet Holdings are trading up 0.82%
Analyst Ratings for Zimmer Biomet Holdings
01:20pm, Wednesday, 04'th May 2022 Benzinga
Within the last quarter, Zimmer Biomet Holdings (NYSE:ZBH) has observed the following analyst ratings:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
4
3
5
1
0
Zimmer Biomet (ZBH) Q1 Earnings Top Estimates, FY22 View Up
02:48pm, Tuesday, 03'rd May 2022 Zacks Investment Research
Each of Zimmer Biomet's (ZBH) geographic segments and product divisions recorded year-over-year sales growth at CER.
Zimmer Biomet Raises, Tightens FY22 Outlook after Q1 Earnings Surpass Estimates
02:05pm, Tuesday, 03'rd May 2022
Zimmer Biomet Holdings Inc's (NYSE: ZBH) Q1 sales increased by 3.9% Y/Y to $1.66 billion (up 6.8% on a constant currency basis), beating the consensus of $1.59 billion. Adjusted EPS was $1.61, whic
Zimmer Biomet Holdings Inc. (ZBH) CEO Bryan Hanson on Q1 2022 Results - Earnings Call Transcript
01:03pm, Tuesday, 03'rd May 2022
Zimmer Biomet Holdings Inc Q1 2022 Earnings Conference Call May 3, 2022 8:30 AM ET Company Participants Bryan Hanson – Chairman, President, and Chief Executive Officer Suky Upadhyay – Executive Vi
Zimmer Biomet (ZBH) Q1 Earnings Top Estimates, FY22 View Up
12:02pm, Tuesday, 03'rd May 2022
Each of Zimmer Biomet's (ZBH) geographic segments and product divisions recorded year-over-year sales growth at CER.
Zimmer Biomet (ZBH) Q1 Earnings and Revenues Surpass Estimates
11:45am, Tuesday, 03'rd May 2022 Zacks Investment Research
Zimmer (ZBH) delivered earnings and revenue surprises of 15% and 4.10%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
